SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 48 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $291,564 | +4.5% | 150,000 | 0.0% | 0.00% | – |
Q4 2022 | $279,047 | +10.7% | 150,000 | 0.0% | 0.00% | – |
Q3 2022 | $252,000 | -93.9% | 150,000 | -95.4% | 0.00% | -100.0% |
Q2 2022 | $4,108,000 | -37.1% | 3,250,000 | -35.0% | 0.01% | -30.0% |
Q1 2022 | $6,535,000 | +62.1% | 5,000,000 | +81.8% | 0.01% | +66.7% |
Q4 2021 | $4,031,000 | -50.3% | 2,750,000 | -50.0% | 0.01% | -53.8% |
Q3 2021 | $8,116,000 | +206.6% | 5,500,000 | +175.0% | 0.01% | +225.0% |
Q2 2021 | $2,647,000 | +1.3% | 2,000,000 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $2,613,000 | +325.6% | 2,000,000 | +700.0% | 0.01% | +400.0% |
Q4 2020 | $614,000 | -60.4% | 250,000 | -66.7% | 0.00% | -75.0% |
Q3 2020 | $1,551,000 | +169.3% | 750,000 | +200.0% | 0.00% | +100.0% |
Q2 2020 | $576,000 | -23.7% | 250,000 | -50.0% | 0.00% | -33.3% |
Q1 2020 | $755,000 | -61.7% | 500,000 | -66.7% | 0.00% | -50.0% |
Q3 2019 | $1,972,000 | – | 1,500,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |